To educate pharmacists about MS pathophysiology and the new American Academy of Neurology recommendations for the use of disease-modifying therapies (DMTs) in adults.
Upon completion of this activity, participants should be better able to:
- DESCRIBE the pathophysiological mechanisms that contribute to multiple sclerosis (MS)
- EVALUATE the safety and efficacy of available disease-modifying therapies
- EMPLOY care coordination strategies that emphasize multidisciplinary collaboration and advocacy for individuals with MS
- DEFINE the pharmacist’s role in providing drug management and administrative support to people receiving MS therapy and their providers